Conversion Study From Cyclosporine to FK506MR Based Immunosuppression in Kidney Transplant Subjects
NCT00481481
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
346
Enrollment
INDUSTRY
Sponsor class
Conditions
Transplantation
Interventions
DRUG:
tacrolimus
Sponsor
Astellas Pharma Inc